Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 169

Results For "NHA"

1863 News Found

Cipla acquires stake in Clean Max Auriga Power
Sustainability | December 16, 2021

Cipla acquires stake in Clean Max Auriga Power

Clean Max Auriga Power is a special purpose vehicle engaged in the business of production, supply and distribution of solar and wind or other renewable energy generation plant


Vakrangee partners with PharmEasy to deliver medicines to remote areas
Digitisation | December 16, 2021

Vakrangee partners with PharmEasy to deliver medicines to remote areas

Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country


Fullife Healthcare raises US $ 22 mn in Series C funding
Startup | December 15, 2021

Fullife Healthcare raises US $ 22 mn in Series C funding

This round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally


Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
Biotech | December 15, 2021

Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme

Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales


Baxter acquires Hillrom for US $ 15 billion
News | December 14, 2021

Baxter acquires Hillrom for US $ 15 billion

It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home


Philips set to acquire Vesper Medical
Medical Device | December 14, 2021

Philips set to acquire Vesper Medical

Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease


Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement
Biotech | December 14, 2021

Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement

Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales


Venus Remedies gets approval under the PLI scheme
News | December 11, 2021

Venus Remedies gets approval under the PLI scheme

Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products


Aerogen partners with CanSinoBIO for aerosolised Covid-19 vaccine
Biotech | December 10, 2021

Aerogen partners with CanSinoBIO for aerosolised Covid-19 vaccine

The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.


Philips receives FDA 510(k) clearance for acute patient monitors
Digitisation | December 09, 2021

Philips receives FDA 510(k) clearance for acute patient monitors

Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support, continuous, scalable patient management and enhanced infection control